The development of a safety profile involves multiple phases of clinical trials, observational studies, and post-marketing surveillance. Initial phases of clinical trials focus on safety and tolerability in small groups of participants. As the trials progress, larger populations are studied to gather data on less common adverse effects. Post-marketing surveillance continues to collect safety data once the intervention is available to the general public.
